The PopVax Chronicles
Subscribe
Sign in
Home
Archive
About
Apocalypse Later: Announcing PopVax Biosecurity
Why PopVax is building the Immune Engine to develop and deploy new medicines against AI-designed viruses in weeks, not years
Jun 8
•
Hannah Herzig
and
Soham Sankaran
10
1
2
One hundred million silver bullets: Generative medicine vs. cancer
Two tumours
Apr 15
•
Soham Sankaran
30
11
v/acc: PopVax’s plan to save 1 million lives each year by massively accelerating vaccine development
The million lives mission
Mar 17
•
Soham Sankaran
25
2
8
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1
PopVax’s influenza vaccine designs elicit as much as 250x greater antibody titer against seasonal strains than existing approved flu vaccines, as well…
Jan 3, 2025
•
Soham Sankaran
6
1
PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA…
We have some exciting news to share:
Dec 22, 2024
•
PopVax
4
1
The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
Broadly-protective mRNA vaccines to save millions of lives
Aug 20, 2023
•
Soham Sankaran
23
The PopVax Chronicles
What it takes to design, test, manufacture, and deploy mRNA vaccines, personalized cancer medicines, and biosecurity therapeutics
Subscribe
Links
PopVax.com
Jobs at PopVax
@PopVaxIndia on X/Twitter
PopVax on Bluesky
PopVax on Linkedin
PopVax YouTube Channel
The PopVax Chronicles
Subscribe
About
Archive
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
